Rafiq Islam

发表

Cystatin C Is a More Reliable Biomarker for Determining eGFR to Support Drug Development Studies

S. Kar, S. Paglialunga, Rafiq Islam, 2018, Journal of clinical pharmacology.

Applications of gold nanoparticles in ELISA, PCR, and immuno-PCR assays: A review.

Marya Ahmed, Rafiq Islam, M. Tabatabaei, 2021, Analytica chimica acta.

2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 - LBA: immunogenicity, biomarkers and PK assays).

Sam H Haidar, Lauren F. Stevenson, Barry van der Strate, 2017, Bioanalysis.

Sensitive glucagon quantification by immunochemical and LC-MS/MS methods.

Rafiq Islam, V. N. Lapko, P. S. Miller, 2013, Bioanalysis.

Adaptation of commercial biomarker kits and proposal for 'drug development kits' to support bioanalysis: call for action.

S. Kar, Rafiq Islam, R. Farmen, 2018, Bioanalysis.

Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis

S. Kar, S. Paglialunga, Rafiq Islam, 2019, PloS one.

2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers).

Sam H Haidar, Olivier Le Blaye, Gustavo Mendes Lima Santos, 2017, Bioanalysis.

White Pa P er SP ecial Focu S iSS ue: Bioanaly S i S o F B iomarker S

Rafiq Islam, R. Lelacheur, S. Reuschel, 2012 .

Recommendations on biomarker bioanalytical method validation by GCC.

Roger Hayes, Fabio Garofolo, John Allinson, 2012, Bioanalysis.

2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 - LBA/cell-based assays: immunogenicity, biomarkers and PK assays).

Neil Henderson, Rong Zeng, Renuka Pillutla, 2018, Bioanalysis.

Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC).

Roger Hayes, Jennifer Zimmer, Xinping Fang, 2012, Bioanalysis.

Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC).

Roger Hayes, Xinping Fang, Zhongping John Lin, 2012, Bioanalysis.

Bioanalytical challenges of biosimilars.

Rafiq Islam, Rafiq Islam, 2014, Bioanalysis.

The 10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraud.

Stephanie Cape, Roger Hayes, Jennifer Zimmer, 2017, Bioanalysis.

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity).

Renuka Pillutla, Viswanath Devanarayan, An Song, 2015, Bioanalysis.

Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond

S. Kar, Rafiq Islam, 2020, Bioanalysis.

Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis.

Stephanie Cape, Roger Hayes, Sumit Kar, 2019, Bioanalysis.

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2 - Hybrid LBA/LCMS and input from regulatory agencies).

Barry Jones, Jianing Zeng, An Song, 2016, Bioanalysis.

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS).

Stephanie Cape, Scott Summerfield, Amanda Wilson, 2016, Bioanalysis.